The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
DRAIZE, J. H., WOODARD, G., & CALVERY, H. O. (1944) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)08751-8 · Cited by 2,602
Donaldson, K., Stone, V, Tran, C. L., Kreyling, W., & Borm, P. J. A. (2004) · Occupational and Environmental Medicine · doi:10.1136/oem.2004.013243 · Cited by 699
Walsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A., Bow, E., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516353 · Cited by 629
Challenges and Opportunities in dermal/transdermal Delivery
Paudel, K. S., Milewski, M., Swadley, C. L., Brogden, N. K., Ghosh, P., & Stinchcomb, A. L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.16 · Cited by 616
Detergent-like actions of linear amphipathic cationic antimicrobial peptides
Bechinger, B., & Lohner, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.001 · Cited by 593
Doktorovova, S., Souto, E. B., & Silva, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.005 · Cited by 419
Self-citationMitri, K., Shegokar, R., Gohla, S., Anselmi, C., & Müller, R. H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.008 · Cited by 404
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery
SHAH, K., DATE, A., JOSHI, M., & PATRAVALE, V (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.061 · Cited by 359
Kovacevic, A., Savic, S., Vuleta, G., Müller, R. H., & Keck, C. M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.036 · Cited by 342
Potential anticancer properties and mechanisms of action of curcumin.
Vallianou, N. G., Evangelopoulos, A. A., Schizas, N., & Kazazis, C. E. (2015) · PubMed · Cited by 340
LOOMIS, D. P. (2006) · Occupational and Environmental Medicine · Cited by 331
Dermatological and Transdermal Formulations
(2002) · CRC Press eBooks · doi:10.1201/9780824743239 · Cited by 323
In vitro skin irritation: facts and future. State of the art review of mechanisms and models
Welss, T., Basketter, D. A., & Schröder, K. R. (2004) · Toxicology in Vitro · doi:10.1016/j.tiv.2003.09.009 · Cited by 311
Gaspar, R., & Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.003 · Cited by 304
Cell culture models of the ocular barriers
Hornof, M., Toropainen, E., & Urtti, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.01.009 · Cited by 300
Paclitaxel nanoparticles for the potential treatment of brain tumors
Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.006 · Cited by 299
Schubert, M. A., & Müller-Goymann, C. C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.03.006 · Cited by 297
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., & Mehnert, W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043315093 · Cited by 265
Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer
Yang, X.-Y., Li, Y.-X., Li, M., Zhang, L., Feng, L.-X., & Zhang, N. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.07.002 · Cited by 262
Nanotoxicity: A Key Obstacle to Clinical Translation of siRNA-Based Nanomedicine
Xue, H. Y., Liu, S., & Wong, H. L. (2014) · Nanomedicine · doi:10.2217/nnm.13.204 · Cited by 250
Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel
Liu, D., Liu, Z., Wang, L., Zhang, C., & Zhang, N. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.038 · Cited by 245
Madane, R. G., & Mahajan, H. S. (2016) · Drug Delivery · doi:10.3109/10717544.2014.975382 · Cited by 241
Luo, Q., Zhao, J., Zhang, X., & Pan, W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.013 · Cited by 234
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug
Jain, A., Agarwal, A., Majumder, S., Lariya, N., Khaya, A., Agrawal, H., Majumdar, S., & Agrawal, G. P. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.003 · Cited by 217
Development of SLNs from natural lipids: Application to topical delivery of tretinoin
Mandawgade, S. D., & Patravale, V. B. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.028 · Cited by 211
Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes
Souto, E. B., & Müller, R. H. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_4 · Cited by 210
Self-citationNafee, N., Husari, A., Maurer, C. K., Lu, C., de Rossi, C., Steinbach, A., Hartmann, R. W., Lehr, C.-M., & Schneider, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.055 · Cited by 208
Raza, K., Singh, B., Lohan, S., Sharma, G., Negi, P., Yachha, Y., & Katare, O. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.019 · Cited by 208
Ramalingam, P., & Ko, Y. T. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1469-1 · Cited by 206
A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers
Li, X., Nie, S.-F., Kong, J., Li, N., Ju, C.-Y., & Pan, W.-S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.017 · Cited by 195
Gartziandia, O., Herran, E., Pedraz, J. L., Carro, E., Igartua, M., & Hernandez, R. M. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.06.054 · Cited by 194
Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery
Gonzalez-Mira, E., Egea, M. A., Souto, E. B., Calpena, A. C., & García, M. L. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/4/045101 · Cited by 180
Self-citationMucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery
Shen, J., Wang, Y., Ping, Q., Xiao, Y., & Huang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.021 · Cited by 179
Biocompatibility of chemically cross-linked gelatin hydrogels for ophthalmic use
Lai, J.-Y. (2010) · Journal of Materials Science: Materials in Medicine · doi:10.1007/s10856-010-4035-3 · Cited by 179
Nassimi, M., Schleh, C., Lauenstein, H. D., Hussein, R., Hoymann, H. G., Koch, W., Pohlmann, G., Krug, N., Sewald, K., Rittinghausen, S., et al. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.02.014 · Cited by 173
Baig, M. S., Ahad, A., Aslam, M., Imam, S. S., Aqil, M., & Ali, A. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.12.077 · Cited by 168
Ramalingam, P., & Ko, Y. T. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.11.050 · Cited by 161
Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery
Fang, J. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s9155 · Cited by 159
Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity
Gokce, E. H., Sandri, G., Bonferoni, M. C., Rossi, S., Ferrari, F., Güneri, T., & Caramella, C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.028 · Cited by 159
Optimization of artemether-loaded NLC for intranasal delivery using central composite design
Jain, K., Sood, S., & Gowthamarajan, K. (2015) · Drug Delivery · doi:10.3109/10717544.2014.885999 · Cited by 158
Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin
Jain, A., Kesharwani, P., Garg, N. K., Jain, A., Jain, S. A., Jain, A., Nirbhavane, P., Ghanghoria, R., Tyagi, R. K., & Katare, O. P. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.06.027 · Cited by 156
Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles
Lippacher, A., Müller, R. H., & Mäder, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00623-2 · Cited by 155
Fangueiro, J. F., Andreani, T., Egea, M. A., García, M. L., Souto, S. B., Silva, A. M., & Souto, E. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.025 · Cited by 152
Self-citationGabal, Y. M., Kamel, A. O., Sammour, O. A., & Elshafeey, A. H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.025 · Cited by 151
Hartmann, N. B., Jensen, K. A., Baun, A., Rasmussen, K., Rauscher, H., Tantra, R., Cupi, D., Gilliland, D. D., Pianella, F., & Sintes, J. M. R. (2015) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2015.1074969 · Cited by 150
What is the current and future status of conventional amphotericin B?
Kleinberg, M. E. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.013 · Cited by 149
Shao, Z., Shao, J., Tan, B., Guan, S., Liu, Z., Zhao, Z., He, F., & Zhao, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77837 · Cited by 148
Raza, K., Singh, B., Singal, P., Wadhwa, S., & Katare, O. P. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.12.043 · Cited by 148
Clift, M. J. D., Gehr, P., & Rothen‐Rutishauser, B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0560-6 · Cited by 144
Clares, B., Calpena, A. C., Parra, A., Abrego, G., Alvarado, H. L., Fangueiro, J. F., & Souto, E. B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.001 · Cited by 144
Self-citationTopical Amphotericin B solid lipid nanoparticles: Design and development
Butani, D., Yewale, C. R., & Misra, A. R. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.07.032 · Cited by 143
Faller, C., Bracher, M. G., Dami, N., & Roguet, R. (2002) · Toxicology in Vitro · doi:10.1016/s0887-2333(02)00053-x · Cited by 139
Gaspar, D. P., Faria, V., Gonçalves, L., Taboada, P., Remuñán‐López, C., & Almeida, A. J. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.11.050 · Cited by 136
Liquid and semisolid SLN™ dispersions for topical application: rheological characterization
Lippacher, A., Müller, R. H., & Mäder, K. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.04.009 · Cited by 132
Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways
Lonez, C., Bessodes, M., Scherman, D., Vandenbranden, M., Escriou, V., & Ruysschaert, J. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.12.003 · Cited by 129
Liu, W., Zhao, X., Chen, Q., Li, Y.-S., Tang, H., Liu, X., & Yang, X. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s73322 · Cited by 126
Xu, P., Yin, Q., Shen, J., Chen, L., Yu, H., Zhang, Z., & Li, Y. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.053 · Cited by 124
Kalhapure, R. S., Mocktar, C., Sikwal, D. R., Sonawane, S. J., Kathiravan, M. K., Skelton, A. A., & Govender, T. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.02.045 · Cited by 124
Castro, G. A., Coelho, A. L. L. R., Oliveira, C. A., Mahecha, G. A. B., Oréfice, R. L., & Ferreira, L. A. M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.025 · Cited by 119
Kovačević, A. B., Müller, R. H., Savic, S. D., Vuleta, G. M., & Keck, C. M. (2013) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2013.12.023 · Cited by 118
Self-citationLippacher, A., Müller, R. H., & Mäder, K. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00233-8 · Cited by 116
Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery
Başaran, E., Demirel, M., Sırmagül, B., & Yazan, Y. (2010) · Journal of Microencapsulation · doi:10.3109/02652040902846883 · Cited by 114
Aditya, N. P., Patankar, S., Madhusudhan, B., Murthy, R. S. R., & Souto, E. B. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.007 · Cited by 111
Self-citationDolatabadi, J. E. N., Hamishehkar, H., Eskandani, M., & Valizadeh, H. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.01.055 · Cited by 107
In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles
Sloat, B. R., Sandoval, M. A., Li, D., Chung, W.-G., Lansakara-P, D. S. P., Proteau, P., Kiguchi, K., DiGiovanni, J., & Cui, Z. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.037 · Cited by 104
Lipid Nanoparticles as Drug/Gene Delivery Systems to the Retina
del Pozo‐Rodríguez, A., Delgado, D., Rodríguez‐Gascón, A., & Solinís, M. Á. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0128 · Cited by 101
Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application
Weyenberg, W., Filev, P., den Plas, D. V., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.045 · Cited by 101
Percutaneous Absorption of Retinoids: Influence of Vehicle, Light Exposure, and Dose
Lehman, P. A., Slattery, J. T., & Franz, T. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12463289 · Cited by 98
Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole
Kakkar, S., Karuppayil, S. M., Raut, J. S., Giansanti, F., Papucci, L., Schiavone, N., & Kaur, I. P. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.088 · Cited by 94
Freitas, C., & Müller, R. H. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289310 · Cited by 94
Chirio, D., Gallarate, M., Peira, E., Battaglia, L., Muntoni, E., Riganti, C., Biasibetti, E., Capucchio, M. T., Valazza, A., Panciani, P. P., et al. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.10.017 · Cited by 94
Investigation on the viscoelastic properties of lipid based colloidal drug carriers
Lippacher, A., Müller, R. H., & Mäder, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00428-7 · Cited by 92
Baek, J.-S., & Cho, C. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.018 · Cited by 92
Aljuffali, I. A., Sung, C. T., Shen, F., Huang, C.-T., & Fang, J. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9550-y · Cited by 92
Leonardi, A., Bucolo, C., Romano, G. L., Platania, C. B. M., Drago, F., Puglisi, G., & Pignatello, R. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.04.061 · Cited by 90
Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit
Leonardi, A., Bucolo, C., Drago, F., Salomone, S., & Pignatello, R. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.032 · Cited by 89
Doktorovová, S., Santos, D. L., Costa, I. H. D. S. E., Andreani, T., Souto, E. B., & Silva, A. M. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.011 · Cited by 88
Self-citationInhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis
Maretti, E., Rossi, T., Bondi, M., Croce, M. A., Hanuskovà, M., Leo, E., Sacchetti, F., & Iannuccelli, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.12.034 · Cited by 86
Battaglia, L., Gallarate, M., Peira, E., Chirio, D., Solazzi, I., Giordano, S., Gigliotti, C. L., Riganti, C., & Dianzani, C. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/25/255102 · Cited by 85
Gokce, E. H., Sandri, G., Eğrilmez, S., Bonferoni, M. C., Güneri, T., & Caramella, C. M. (2009) · Current Eye Research · doi:10.3109/02713680903261405 · Cited by 84
Sanna, V., Kirschvink, N. A., Gustin, P. G., Gavini, E., Roland, I. H., Delattre, L., & Évrard, B. (2004) · AAPS PharmSciTech · doi:10.1208/pt050227 · Cited by 83
Keck, C. M., Kovačević, A. B., Müller, R. H., Savic, S. D., Vuleta, G. M., & Milić, J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.008 · Cited by 83
Self-citationTran, T. H., Ramasamy, T., Truong, D. H., Shin, B. S., Choi, H., Yong, C. S., & Kim, J. O. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1300-z · Cited by 82
Influence of Emulsion Droplet Surface Charge on Indomethacin Ocular Tissue Distribution
Klang, S. H., Abdulrazik, M., & Benita, S. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100102035 · Cited by 80
Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A
Patel, P. A., Patil, S. C., Kalaria, D. R., Kalia, Y. N., & Patravale, V. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.014 · Cited by 74
PEGylated nanostructured lipid carriers (PEG–NLC) as a novel drug delivery system for biochanin A
Wang, L., Luo, Q., Lin, T., Li, R., Zhu, T., Zhou, K., Ji, Z., Song, J.-W., Jia, B., Zhang, C., et al. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.938082 · Cited by 74
Weyhers, H., Ehlers, S., Hahn, H. H., et al. (2006) · PubMed · Cited by 73
Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles
Akanda, M., Rai, R., Slipper, I. J., Chowdhry, B. Z., Lamprou, D. A., Getti, G. T. M., & Douroumis, D. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.042 · Cited by 73
Hwang, T., Aljuffali, I. A., Hung, C., Chen, C., & Fang, J. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.04.011 · Cited by 73
Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery
Bikkad, M. L., Nathani, A. H., Mandlik, S. K., Shrotriya, S. N., & Ranpise, N. S. (2013) · Journal of Liposome Research · doi:10.3109/08982104.2013.843192 · Cited by 73
Solid lipid nanoparticles loaded with lipoyl–memantine codrug: Preparation and characterization
Laserra, S., Basit, A., Sozio, P., Marinelli, L., Fornasari, E., Cacciatore, I., Ciulla, M., Türkez, H., Geyikoglu, F., & Di Stefano, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.001 · Cited by 72
Formulation of tocopherol nanocarriers and in vitro delivery into human skin
Abla, M. J., & Banga, A. K. (2014) · International Journal of Cosmetic Science · doi:10.1111/ics.12119 · Cited by 72
Guo, T., Zhang, Y., Zhao, J., Zhu, C., & Feng, N. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0107-3 · Cited by 71
Goulart, G. A. C., Oliveira, C. A., Mahecha, G. A. B., & Ferreira, L. A. M. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-011-1130-3 · Cited by 71
Schwarz, J. C., Weixelbaum, A., Pagitsch, E., Löw, M., Resch, G. P., & Valenta, C. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.003 · Cited by 71
Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential
Girotra, P., Singh, S. K., & Kumar, P. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.035 · Cited by 68
Brugè, F., Damiani, E., Puglia, C., Offerta, A., Armeni, T., Littarru, G. P., & Tiano, L. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.075 · Cited by 68
Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement
Shen, J., Sun, M., Ping, Q. N., Zhi, Y., & Liu, W. (2009) · Nanotechnology · doi:10.1088/0957-4484/21/2/025101 · Cited by 68
Cyclosporine A Formulation Affects Its Ocular Distribution in Rabbits
Kuwano, M., Ibuki, H., Morikawa, N., Ota, A., & Kawashima, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1013671819604 · Cited by 67
Bi, X., Yuan, Q., Han, J., Cong, W., Ge, Y., Ma, D., Dai, Z., & Li, Y. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s70919 · Cited by 67
Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells
Kuo, Y., & Liang, C.-T. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.02.011 · Cited by 64
Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells
Shah, R., Rajasekaran, D., Ludford‐Menting, M., Eldridge, D. S., Palombo, E. A., & Harding, I. H. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.029 · Cited by 64
Harde, H., Agrawal, A. K., Katariya, M., Kale, D. P., & Jain, S. (2015) · RSC Advances · doi:10.1039/c5ra06047h · Cited by 63
Li, J., Guo, X., Liu, Z., Okeke, C. I., Li, N., Zhao, H., Aggrey, M. O., Pan, W., & Wu, T. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.795582 · Cited by 58
Bonifácio, B. V., Ramos, M. A. D. S., da Silva, P. B., Negri, K. M. S., Lopes, É. O., Souza, L., Vilegas, W., Pavan, F. R., Chorilli, M., & Bauab, T. M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s79684 · Cited by 57
Eskandani, M., & Nazemiyeh, H. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.04.009 · Cited by 57
Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity
Blasi, P., Schoubben, A., Traina, G., Manfroni, G., Barberini, L., Alberti, P. F., Cirotto, C., & Ricci, M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.037 · Cited by 57
Brugè, F., Damiani, E., Marcheggiani, F., Offerta, A., Puglia, C., & Tiano, L. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.033 · Cited by 56
Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery
Yu, W., Liu, C., Ye, J., Zou, W., Zhang, N., & Xu, W. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/21/215102 · Cited by 53
Nanostructured Polymer and Lipid Carriers for Sunscreen. Biological Effects and Skin Permeation
Marcato, P. D., Caverzan, J., Rossi‐Bergmann, B., Pinto, E. F., Machado, D., da Silva, R. A., Justo, G. Z., Ferreira, C. V., & Durán, N. (2011) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2011.3135 · Cited by 50
Chen, Z., Lai, X., Song, S., Zhu, X., & Zhu, J. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1038857 · Cited by 49
In vitroandex vivotoxicological testing of sildenafil-loaded solid lipid nanoparticles
Paranjpe, M., Neuhaus, V., Finke, J. H., Richter, C., Gothsch, T., Kwade, A., Büttgenbach, S., Braun, A. C., & Müller-Goymann, C. C. (2013) · Inhalation Toxicology · doi:10.3109/08958378.2013.810315 · Cited by 48
Roxithromycin-loaded lipid nanoparticles for follicular targeting
Wosicka-Frąckowiak, H., Cal, K., Stefanowska, J., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.068 · Cited by 47
The effect of lipid nanoparticle PEGylation on neuroinflammatory response in mouse brain
Huang, J.-Y., Lu, Y., Wang, H., Liu, J., Liao, M.-H., Hong, L.-J., Tao, R., Ahmed, M. M., Liu, P., Liu, S.-S., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.009 · Cited by 44
In vitro biocompatibility of solid lipid nanoparticles
Silva, A. H., Filippin-Monteiro, F. B., Mattei, B., Zanetti-Ramos, B. G., & Creczynski‐Pasa, T. B. (2012) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2012.06.018 · Cited by 42
Vitamin B12-loaded solid lipid nanoparticles as a drug carrier in cancer therapy
Genç, L., Kutlu, H. M., & Eskiler, G. G. (2013) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2013.867447 · Cited by 41
Kuo, Y., & Lee, I.-H. (2016) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2015.12.012 · Cited by 38
Negi, L. M. S., Talegaonkar, S., Jaggi, M., Verma, A. K., Verma, R., Dobhal, S., & Kumar, V. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.09.061 · Cited by 37
Lawlor, C., O’Sullivan, M. P., Sivadas, N., O’Leary, S. M., Gallagher, P., Keane, J., & Cryan, S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp1004178 · Cited by 36
Shete, H. K., Selkar, N., Vanage, G. R., & Patravale, V. B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.03.056 · Cited by 35
Solid lipid nanoparticles reduce systemic toxicity of docetaxel: Performance and mechanism in animal
Gao, Y., Yang, R., Zhang, Z., Chen, L., Sun, Z., & Li, Y. (2011) · Nanotoxicology · doi:10.3109/17435390.2010.551427 · Cited by 30
Antioxidant activity of idebenone-loaded neutral and cationic solid–lipid nanoparticles
Leonardi, A., Crascì, L., Panico, A., & Pignatello, R. (2014) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.915572 · Cited by 30
Shi, L., Cao, Y. Z., Zhu, X.-Y., Cui, J.-H., & Cao, Q. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.017 · Cited by 29
Tran, T. H., Chu, D. T., Truong, D. H., Tak, J. W., Jeong, J., Hoang, V. L., Yong, C. S., & Kim, J. O. (2014) · Drug Delivery · doi:10.3109/10717544.2014.991432 · Cited by 29
Nighland, M., Yusuf, M., Wisniewski, S. R., et al. (2006) · PubMed · Cited by 29
Bondı̀, M. L., Ferraro, M., Vincenzo, S. D., Gerbino, S., Cavallaro, G., Giammona, G., Botto, C., Gjomarkaj, M., & Pace, E. (2014) · Journal of Nanobiotechnology · doi:10.1186/s12951-014-0046-4 · Cited by 27
Solid lipid nanoparticles induced hematological changes and inflammatory response in mice
Silva, A. H., Locatelli, C., Filippin-Monteiro, F. B., Zanetti-Ramos, B. G., Conte, A., & Creczynski‐Pasa, T. B. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.782076 · Cited by 26
Kasongo, K. W., Jansch, M., Müller, R. H., & Walker, R. B. (2010) · Journal of Liposome Research · doi:10.3109/08982104.2010.539186 · Cited by 25
Development of DH-I-180-3 loaded lipid nanoparticle for photodynamic therapy
Park, J.-H., Ban, S.-J., Ahmed, T., Choi, H. S., Yoon, H., Yoon, J., & Choi, H. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.002 · Cited by 24
Bhushan, S., Kakkar, V., Pal, H. C., Mondhe, D. M., & Kaur, I. P. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.022 · Cited by 22
Kyadarkunte, A., Patole, M. S., & Pokharkar, V. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.044 · Cited by 21
Nanotechnology in Ophthalmic Drug Delivery: A Survey of Recent Developments and Patenting Activity
Pignatello, R., & Puglisi, G. (2011) · Current Nanomedicine · doi:10.2174/1877912311101010042 · Cited by 21
Soddu, E., Rassu, G., Cossu, M., Giunchedi, P., Cerri, G., & Gavini, E. (2014) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.971376 · Cited by 20
Sacchetti, F., Marraccini, C., D’Arca, D., Pelà, M., Pinetti, D., Maretti, E., Hanuskovà, M., Iannuccelli, V., Costi, M. P., & Leo, E. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.09.040 · Cited by 19
Lakkadwala, S., Nguyen, S., Lawrence, J. G., Nauli, S. M., & Nesamony, J. (2014) · Journal of Microencapsulation · doi:10.3109/02652048.2014.898707 · Cited by 15
Cited by
Mohammadi-Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 970
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Scioli Montoto, S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 652
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
Viegas, C., Patrício, A. B., Prata, J. M., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 524
Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier
Salvi, V. R., & Pawar, P. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.02.017 · Cited by 456
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
Haider, M., Abdin, S. M., Kamal, L., & Orive, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030288 · Cited by 451
Metadata
- Authors
- Doktorovová, S., Kovačević, A. B., Garcia, M. L., & Souto, E. B.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 108
- Pages
- 235-252
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2512448728
- Cited by
- 293
- References
- 139
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.